Archive for the ‘ Inc. EFSF’ Category Inc. (EFSF.OB): Healthy Profits for Investors?

Wednesday, August 20th, 2008 (EFSF) is a developer of nutraceutical products to help improve an array of health conditions for consumers. Nutraceutical products are defined by their combination of natural foods and supplements and the market for such products is estimated to reach $845 billion by 2015.

eFoodSafety’s products focus on wellness issues including lowered cholesterol, boosted metabolism, acne prevention and scarring reduction. The company’s Cinnergen product, which is used to provide nutrients to metabolize blood sugar, is currently available in major retailers such as GNC, Rite Aid and Vitamin Shoppe.

The Arizona-based company’s Cinnechol product is used to naturally treat cholesterol problems and competes in a $20-billion market. eFoodSafety is also working on products to treat skin problems, including acne, and staph infections and viruses. The company’s popular Boost Bar is used by health-conscious consumers to boost their immune systems. In June, the company said its OraPhyt product, which is used to kill bacteria, fungi and mold in food, received patent approval from the U.S. Patent and Trademark Office.

The company also makes products to combat bacterial diseases and infections, as well as the tick-borne infection called Lyme disease, and appears well-positioned to continue bolstering its product offerings. eFoodSafety has about $1.51 million in total cash and slashed its fiscal 2007 loss to $3.6 million from $9.4 million in fiscal 2006. The company also carries no long-term debt at the moment. With a market cap of almost $12.5 million, eFoodSafety shares trade around 7 cents each with an average daily volume of about 261,000 for the last three months.

Let us hear your thoughts below:, Inc. (EFSF.OB) Strengthens Its Financial Position with Revenue Growth

Tuesday, March 18th, 2008, a developer of nutraceutical and whole food products, has reported its quarterly results for the company’s fiscal third quarter ended January 31, 2008. The company’s financial highlights are as follows:

• The company is showing a 300% increase in revenue for the quarter ended January 31, 2008. Net sales were $309,197 as compared to $82,930 for the same period ended January 31, 2007.

• There was a decrease in sales and marketing expenses of 52%. Net sales and expenses reported January 31, 2007 were $54,387 compared to $28,455 for the quarter ended January 31, 2008.

• Research and development expenses showed an 83% decrease from the previous year. R&D expenses were $8,381 for the quarter ended January 31, 2008 as compared with $49,051 for the same period ended January 31, 2007.

• However, general and administrative expenses increased approximately 15.6% from the previous year, with general and admin expenses totaling $222,756 for the quarter ended January 31, 2008 compared to $192,615 for the same period ended January 31, 2007. The company believes that this is due to higher insurance costs and increased liability limits for all divisions, stemming from increased product sales.

Patricia Gruden, CEO and Chairman of eFoodSafety commented on the company’s financial position stating, “Reporting year-over-year quarterly revenue growth of 300% for our fiscal third quarter is an encouraging way to embark upon what management anticipates will be a very promising year for the Company, including solid revenue growth, especially in conjunction with the imminent launch of our direct response campaigns for Cinnergen™ and Cinnechol™.”

“We have delivered on our goal of building the foundation to support our products through consumer rollouts and continued R&D. At the same time, we continued to control our expenses, and this quarter’s results certainly reflect our achievements in those efforts. We can proudly report to our shareholders and investment community that the majority of our products are ready for market. We continue to remain in a very strong financial position with over $1 million in cash on hand after disbursements for all expenses,” she continued.

Let us hear your thoughts below:

Small Cap Voice Featured Client:, Inc. (EFSF.OB)

Thursday, March 13th, 2008, Inc. (EFSF.OB) is a leader in the research and development of nutraceutical products for a wide range of markets. The Company’s focus is on developing, licensing and co-marketing unique, best-of-breed products that address the health needs of consumers worldwide. The company is dedicated to improving the quality of life around the world. EFSF’s subsidiaries and ownership claims include Knock-Out Technologies, Ltd., MedElite, Inc., Cinnergen, and CK41 Direct.

Knock-Out Technologies, Ltd. has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax, and a germicidal product, Citroxin™ (formerly named Big Six Plus), that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, Streptococcus, Avian Influenza, and Black Mold. The OraPhyte™ product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

Cinnergen™ is a clinically-studied, non-prescription whole food nutritional supplement that promotes healthy glucose metabolism. It is available at their website and through national retailers. Cinnechol™ is a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

iBoost, Inc. is the distributor of the Immune Boost Bar™, a non-dairy, all-natural and comprehensive multi-nutrient product that helps fortify the body’s immune system. The product contains Citroxin™, eFoodSafety’s proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar™ is available in four delicious flavors: chocolate, oatmeal-raisin, mint and peanut butter.

MedElite, Inc. distributes clinically proven products to physicians, who then prescribe the products for their patients. It is the owner of the Talsyn™-CI/bid Scar Cream, a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars. Talsyn™ also has 7 other products in its line.

Let us hear your thoughts:, Inc. Message Board Inc. (EFSF.OB) Seeking to Make the World a Better Place

Monday, February 4th, 2008, Inc. is dedicated to improving health conditions around the world through its innovative technologies. Their dedicated team strives to achieve this goal by developing and marketing unique products that address the health and nutrition needs of consumers worldwide. eFoodSafety identifies markets with the potential for mass product sales, then researches develops and markets products that address the specific health and nutritional needs of those markets.

The eFoodSafety family of companies includes subsidiary Knock-Out Technologies, Ltd. which has developed an environmentally safe sporicide that eradicates anthrax, formulated entirely with food grade ingredients; MedElite, Inc. which distributes clinically proven products to consumers through a physicians’ network; and the company markets whole food supplements Cinnergen, which promotes healthy glucose metabolism. eFoodSafety has also entered into a joint venture agreement with CK41 Direct, Inc. to launch and market the PurEffect Acne Treatment System.

The company is headed up by “serial entrepreneur”, Patricia Ross-Gruden – President and CEO, Timothy Matula, Bob Bowker and Nutritionist Steven Kushner, PhD.

In recent events, efoodsafety has engaged Respond2 Communications Inc., a full-service response-driven advertising agency, to launch direct-response campaigns for three of its products. Respond2 Communications, an advertising agency that focuses on targeting consumers with eye-catching, creative branding information and compelling reasons to purchase, will work closely with eFoodSafety to initiate the direct-response marketing campaigns.

They have also retained the Investor Relations Group, Inc. (IRG), a thirteen-year-old, highly-recognized corporate communications firm to serve as its national public relations and investor relations firm. The Investor Relations Group’s award-winning healthcare public relations department will initiate an outreach campaign to the media-at-large with the primary focus of educating the public about eFoodSafety’s unique nutraceutical products.

eFoodSafety Inc. was featured in the January 2008 issue of The KonLin Letter (TKL), an independent market letter that research, analyzes, and recommends stocks. Konrad Kuhn, editor of The KonLin Letter pointed out that the company has “turned the corner to commercialization,” and has “showed significant progress during FY’07” including a more than 100% increase in revenues year-over-year and improvements to the balance sheet.”

Let us hear your thoughts below: